Comparing patient OOP spending for specialty drugs in Medicare Part D and employer-sponsored insurance.
CONCLUSIONS: OOP spending was substantially higher for Medicare enrollees compared with ESI enrollees as a result of the Part D benefit structure.
PMID: 32930551 [PubMed - in process]
Source: The American Journal of Managed Care - Category: Health Management Authors: Parasrampuria S, Sen AP, Anderson GF Tags: Am J Manag Care Source Type: research
More News: Arthritis | Cancer | Cancer & Oncology | Health Management | Hepatitis | Hepatitis C | Insurance | Managed Care | Medicare | Multiple Sclerosis | Rheumatoid Arthritis | Rheumatology | Study